AI In Clinical Trials Market Report 2026

AI In Clinical Trials Market Overview

• AI In Clinical Trials market size has reached to $9.16 billion in 2025 • Expected to grow to $54.71 billion in 2030 at a compound annual growth rate (CAGR) of 43% • Growth Driver: AI in Clinical Trials Market Surges With The Escalating Incidence Of Chronic And Infectious Diseases • Market Trend: Strategic Partnerships Harness AI To Accelerate Patient Recruitment And Enhance Workflow Efficiencies • North America was the largest region in 2025.

What Is Covered Under AI In Clinical Trials Market?

AI in clinical trials refers to the application of artificial intelligence (AI) technologies and techniques in the planning, design, execution, and analysis of clinical trials. Clinical trials are rigorous research studies that evaluate the safety and effectiveness of medical interventions, such as new drugs, medical devices, or treatment protocols, in human subjects. The main offerings for AI in clinical trials are software and services. AI in clinical trial services refers to the services that are used to investigate and generate insight from past and current clinical trials. The various processes include trial design, patient selection, site selection, and patient monitoring with various technologies such as machine learning, deep learning, supervised learning, other machine learning technologies, and others. These are applied in various applications such as oncology, neurological diseases and condition, cardiovascular diseases, metabolic diseases, infectious diseases, and immunology diseases, and are used by various end-users such as pharmaceuticals and biotechnology companies, contract research organizations, and others.

What Is The AI In Clinical Trials Market Growth Forecast?

The AI in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $54.71 billion in 2030 at a compound annual growth rate (CAGR) of 43.0%. The growth in the forecast period can be attributed to expansion of decentralized clinical trials, increasing adoption of real world evidence, growth of precision medicine, rising regulatory acceptance of AI tools, advancements in healthcare analytics. Major trends in the forecast period include AI driven patient recruitment, predictive trial outcome modeling, automated clinical data analysis, remote patient monitoring integration, adaptive trial design adoption.

Global AI In Clinical Trials Market Segmentation

1) By Offering: Software, Services 2) By Process: Trial Design, Patient Selection, Site Selection, Patient Monitoring 3) By Technology: Machine Learning, Deep Learning, Supervised Learning, Other Technologies 4) By Application: Oncology, Neurological Diseases And Condition, Cardiovascular Diseases, Metabolic Diseases, Infectious Diseases, Immunology Diseases, Other Applications 5) By End-User: Pharmaceuticals And Biotechnology Companies, Contract Research Organizations, Other End-Users Subsegments: 1) By Software: Clinical Trial Management Systems (CTMS), Data Analytics Software, Predictive Analytics Tools, Patient Recruitment And Retention Software, Real-World Evidence Platforms 2) By Services: Consulting Services, Data Management And Analysis Services, Training And Support Services, Regulatory Compliance Services

What Is The Driver Of The AI In Clinical Trials Market?

Rising incidences of chronic and infectious diseases are expected to propel the growth of the AI in clinical trials market going forward. Chronic disease refers to a form of illness that lasts for three months or more and can deteriorate with time. Artificial intelligence in clinical trials is helpful to develop various drugs for treating chronic diseases. For instance, in August 2024, according to the Macmillan Cancer Support, a UK-based organization, reported that in 2024, more than 3 million people in the UK are living with cancer, this figure is projected to increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Therefore, the rising incidences of chronic and infectious diseases are driving the growth of the AI in the clinical trials market.

Key Players In The Global AI In Clinical Trials Market

Major companies operating in the AI in clinical trials market are ConcertAI Inc.; Owkin Inc.; AiCure Technologies Inc.; Ardigen S.A.; Unlearn.AI Inc.; PathAI Inc.; Exscientia plc; VeriSIM Life Inc.; Envisagenics Inc.; NURITAS Limited; BioSymetrics Inc.; Trials.AI Inc.; IQVIA Holdings Inc.; Euretos B.V.; Saama Technologies LLC; Deep 6 AI Inc.; Medidata Solutions Inc.; Antidote Technologies Inc.; Castor EDC B.V.; TrialSpark Inc.; Phesi S.A.; CluePoints NV

Global AI In Clinical Trials Market Trends and Insights

Major companies operating in the AI in clinical trials market are adopting a strategic partnership approach to deliver research tools and workflow efficiencies that result in improved timelines and increased patient recruitment. Strategic partnerships refer to a process in which companies leverage each other's strengths and resources to achieve mutual benefits and success. For instance, in February 2023, a US-based pharmaceutical commercial company partnered with Haystack Health, a US-based software development company. With this partnership, they aim to leverage AI and Natural Language Processing (NLP) to speed up clinical trials, improve patient recruitment, and reduce the screen failure rate through the use of clinical AI and pre-screening services, which can be costly in terms of time and money.

What Are Latest Mergers And Acquisitions In The AI In Clinical Trials Market?

In April 2024, Clario, a US-based provider of data-solutions and clinical trial technology company, acquired ArtiQ for an undisclosed amount. With this acquisition, Clario aims to enhance its artificial intelligence-driven respiratory solutions and strengthen its overall AI/ML capability across clinical trial endpoints. ArtiQ is a Belgium-based provider of AI-powered software that supports diagnosis, monitoring and optimization of respiratory clinical trials through advanced machine-learning models.

Regional Insights

North America was the largest region in the AI in clinical trials market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the AI In Clinical Trials Market?

The AI in clinical trials market consists of revenues earned by entities by providing AI software solutions and platforms designed to assist in various aspects of clinical trials, such as trial design, patient recruitment, data collection, monitoring, and analysis, data analytics and insights, predictive modeling and simulation, regulatory compliance, and safety monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The AI in clinical trials also includes sales of computer vision technology, cognitive computing, and machine translation technologies which are used in providing clinical trials. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the AI In Clinical Trials Market Report 2026?

The ai in clinical trials market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ai in clinical trials industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.